BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02420873-completion@plaintrial.com
DTSTAMP:20260928T145214Z
DTSTART;VALUE=DATE:20170606
SUMMARY:An Open-label Phase II Study of Lorvotuzumab Mertansine — estimat
 ed completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT02420873
URL:https://plaintrial.com/trial/NCT02420873
END:VEVENT
END:VCALENDAR